{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T17:15:21Z","timestamp":1792689321830,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,2]],"date-time":"2021-11-02T00:00:00Z","timestamp":1635811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","award":["2018ZX10103001"],"award-info":[{"award-number":["2018ZX10103001"]}],"id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2019YFC0840602"],"award-info":[{"award-number":["2019YFC0840602"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2020YFA0907200"],"award-info":[{"award-number":["2020YFA0907200"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalmicrobiologyandinfection.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/j.cmi.2021.09.014","type":"journal-article","created":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T06:07:41Z","timestamp":1632982061000},"page":"731.e9-731.e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China"],"prefix":"10.1016","volume":"28","author":[{"given":"Dongxin","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wencong","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xichao","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baoli","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyuan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunfa","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengfen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick W.","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanlin","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.cmi.2021.09.014_bib1","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0140-6736(15)60570-0","article-title":"WHO\u2019s new end TB strategy","volume":"385","author":"Uplekar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.cmi.2021.09.014_bib2","author":"World Health Organization"},{"key":"10.1016\/j.cmi.2021.09.014_bib3","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1056\/NEJMoa1108789","article-title":"National survey of drug-resistant tuberculosis in China","volume":"366","author":"Zhao","year":"2012","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.014_bib4","doi-asserted-by":"crossref","first-page":"e01504","DOI":"10.1128\/JCM.01504-19","article-title":"Genotyping of Mycobacterium tuberculosis rifampin resistance-associated mutations by use of data from Xpert MTB\/RIF ultra enables large-scale tuberculosis molecular epidemiology studies","volume":"58","author":"Weinrick","year":"2019","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib5","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1128\/JCM.05723-11","article-title":"Genotype MTBDRplus for direct detection of Mycobacterium tuberculosis and drug resistance in strains from gold miners in South Africa","volume":"50","author":"Dorman","year":"2012","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib6","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1016\/S1473-3099(18)30496-1","article-title":"Outbreak of multidrug-resistant tuberculosis in South Africa undetected by WHO-endorsed commercial tests: an observational study","volume":"18","author":"Makhado","year":"2018","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.cmi.2021.09.014_bib7","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1056\/NEJMoa1800474","article-title":"Prediction of susceptibility to first-line tuberculosis drugs by DNA sequencing","volume":"379","author":"Allix-B\u00e9guec","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.014_bib8","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1093\/cid\/ciy346","article-title":"Intermediate susceptibility dose-dependent breakpoints for high-dose rifampin, isoniazid, and pyrazinamide treatment in multidrug-resistant tuberculosis programs","volume":"67","author":"Zuur","year":"2018","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.cmi.2021.09.014_bib9","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1056\/NEJMoa1715849","article-title":"Bacterial factors that predict relapse after tuberculosis therapy","volume":"379","author":"Colangeli","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.cmi.2021.09.014_bib10","doi-asserted-by":"crossref","first-page":"e01885-20","DOI":"10.1128\/JCM.01885-20","article-title":"Low-level rifampin resistance and rpoB mutations in Mycobacterium tuberculosis: an analysis of whole-genome sequencing and drug susceptibility test data in New York","volume":"59","author":"Shea","year":"2021","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1128\/AAC.01209-13","article-title":"Sensititre MYCOTB MIC plate for testing Mycobacterium tuberculosis susceptibility to first- and second-line drugs","volume":"58","author":"Lee","year":"2014","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.cmi.2021.09.014_bib12","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1128\/JCM.03162-15","article-title":"Direct susceptibility testing of Mycobacterium tuberculosis for pyrazinamide by use of the Bactec MGIT 960 System","volume":"54","author":"Demers","year":"2016","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MCP.0b013e3283452346","article-title":"New and improved diagnostics for detection of drug-resistant pulmonary tuberculosis","volume":"17","author":"O'Grady","year":"2011","journal-title":"Curr Opin Pulm Med"},{"key":"10.1016\/j.cmi.2021.09.014_bib14","series-title":"WHO guidelines approved by the guidelines review committee, policy guidance on drug-susceptibility testing (dst) of second-line antituberculosis drugs","author":"Barrera","year":"2008"},{"key":"10.1016\/j.cmi.2021.09.014_bib15","doi-asserted-by":"crossref","first-page":"2578","DOI":"10.1128\/jcm.29.11.2578-2586.1991","article-title":"Occurrence and stability of insertion sequences in Mycobacterium tuberculosis complex strains: evaluation of an insertion sequence-dependent DNA polymorphism as a tool in the epidemiology of tuberculosis","volume":"29","author":"van Soolingen","year":"1991","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib16","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1101\/gr.111120.110","article-title":"A\u00a0statistical algorithm for sensitive and fast mapping of Illumina sequence reads","volume":"21","author":"Lunter","year":"2011","journal-title":"Genome Res"},{"key":"10.1016\/j.cmi.2021.09.014_bib17","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/bioinformatics\/btp352","article-title":"The sequence alignment\/map format and SAMtools","volume":"25","author":"Li","year":"2009","journal-title":"Bioinformatics"},{"key":"10.1016\/j.cmi.2021.09.014_bib18","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/ng.1028","article-title":"De novo assembly and genotyping of variants using colored de Bruijn graphs","volume":"44","author":"Iqbal","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2021.09.014_bib19","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/ng.2878","article-title":"Evolution and transmission of drug-resistant tuberculosis in a Russian population","volume":"46","author":"Casali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/j.cmi.2021.09.014_bib20","doi-asserted-by":"crossref","first-page":"3501","DOI":"10.1128\/JCM.01209-09","article-title":"Mycobacterium tuberculosis strains with highly discordant rifampin susceptibility test results","volume":"47","author":"Van Deun","year":"2009","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib21","doi-asserted-by":"crossref","first-page":"216","DOI":"10.5588\/ijtld.11.0178","article-title":"Clinical failures associated with rpoB mutations in phenotypically occult multidrug-resistant Mycobacterium tuberculosis","volume":"16","author":"Williamson","year":"2012","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2021.09.014_bib22","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.5588\/ijtld.13.0195","article-title":"Proficiency of drug susceptibility testing of Mycobacterium tuberculosis against pyrazinamide: the Swedish experience","volume":"17","author":"Hoffner","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/j.cmi.2021.09.014_bib23","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1128\/JCM.01001-15","article-title":"Mycobacterium tuberculosis pncA polymorphisms that do not confer pyrazinamide resistance at a breakpoint concentration of 100 micrograms per milliliter in MGIT","volume":"53","author":"Whitfield","year":"2015","journal-title":"J\u00a0Clin Microbiol"},{"key":"10.1016\/j.cmi.2021.09.014_bib24","doi-asserted-by":"crossref","first-page":"1332","DOI":"10.1016\/j.cmi.2020.07.004","article-title":"Identifying isoniazid resistance markers to guide inclusion of high-dose isoniazid in tuberculosis treatment regimens","volume":"26","author":"Rivi\u00e8re","year":"2020","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.cmi.2021.09.014_bib25","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.2169\/internalmedicine.9571-17","article-title":"Successful treatment with a high-dose rifampin-containing regimen for pulmonary tuberculosis with a disputed rpoB mutation","volume":"57","author":"Jeong","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.cmi.2021.09.014_bib26","series-title":"WHO consolidated guidelines on drug-resistant tuberculosis treatment","author":"World Health Organization","year":"2019"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21005346?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X21005346?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T12:31:41Z","timestamp":1741696301000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X21005346"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5]]},"references-count":26,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S1198743X21005346"],"URL":"https:\/\/doi.org\/10.1016\/j.cmi.2021.09.014","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Whole-genome sequencing for surveillance of tuberculosis drug resistance and determination of resistance level in China","name":"articletitle","label":"Article Title"},{"value":"Clinical Microbiology and Infection","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cmi.2021.09.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2021 Published by Elsevier Ltd on behalf of European Society of Clinical Microbiology and Infectious Diseases.","name":"copyright","label":"Copyright"}]}}